#Cramer Shares His Thoughts: He wouldn't buy $TEVA. He explained that it's a generic drugmaker and those stocks are pretty awful in comparison to $MRK, $PFE and $BMY. No to $OXM, yes to $PVH. Yes to $AMGN and its new oncological franchise. #MarketUpdate https://t.co/BIV6sr226t